Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03361865
Brief Title: Pembrolizumab in Combination With Epacadostat or Placebo in Cisplatin-ineligible Urothelial Carcinoma (KEYNOTE-672/ECHO-307)

First Submitted : November 29, 2017
First Submitted that Met QC Criteria : November 29, 2017
First Posted : December 5, 2017

Results First Submitted : August 9, 2019
Results First Submitted that Met QC Criteria : August 27, 2019
Results First Posted : August 29, 2019

Last Update Submitted that Met QC Criteria : August 26, 2020
Last Update Posted : September 14, 2020